| |
Market
For different reasons, in the last few years patient recruitment has slowed down in developed countries.
Pharmaceutical companies and other entities are shifting operations to Latin America, Asia, Central and Eastern Europe where they can find trial naïve study patients, lower costs and streamline operations.
Latin America, and in particular Argentina, continuous to offer unparalleled benefits to any clinical development program.
|
